BTK Inhibitors | Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors

Research To Practice | Oncology Videos · Feb 23, 2023 · 1h 3m

Featuring perspectives from Drs Farrukh Awan and Kelly Rogers, including the following topics:

• Case: A woman in her early 90s with underlying chronic obstructive pulmonary disease was observed for 20 years for chronic lymphocytic leukemia (CLL) before initiating treatment with acalabrutinib and quickly develops fatigue, headache and diarrhea — Erik Rupard, MD (16:56)

• Case: A frail man in his late 80s with CLL requiring treatment develops nonspecific side effects with acalabrutinib — Neil Morganstein, MD (29:44)

• Case: A man in his late 80s with CLL was observed for 28 years before…